Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
CPSC Recall1 injuries · 2022-06-30 · 22754
Hazards
The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.
Recall
Number
22754
Date
2022-06-30
Injuries reported
1
Products
Names
Lidocaine 4% Topical Anesthetic Cream
Remedies
Options
Refund
Companies
Manufacturer(s)
Mohnark Pharmaceuticals Inc., of Davie, Fla.
Retailer(s)
Online at Amazon.com and Walmart.com from January 2021 through January 2022 for about $7.
Country of manufacture
United States
Description
The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.